Hikma Agrees to Buy EIMC United Pharmaceutical in Egypt

 In news

Hikma has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals from a consortium of shareholders to strengthen position in Egypt.

* Expands portfolio in oncology and injectables, with the potential to add around 50 products by 2020. Source: Bloomberg

Recent Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search